多发性硬化症的主要抑郁症与疾病修饰疗法和人口统计学方面的差异有关
Nathanael J Lee1,2, Gavin Hui3, C William Pike3
1Division of Neuroimmunology and Neurological Infections, Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Frontiers in neurology
|October 1, 2025
概括
患有多发性硬化症 (pwMS) 的黑人更有可能患有重度抑郁症 (MDD) 并发症. 在pwMS中,MDD影响治疗时间表和医疗保健使用.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 流行病学 流行病学
背景情况:
- 大型抑郁症 (MDD) 经常与多发性硬化症 (MS) 同时发生.
- 对于这种并发症的人口学关联和临床影响的了解有限.
- 调查pwMS中MDD的人口因素和临床结果至关重要.
研究的目的:
- 检查人口统计学特征与MS和MDD共同诊断之间的相关性.
- 评估MDD并发症对pwMS临床结果的影响.
- 了解MDD诊断时间如何影响结果.
主要方法:
- 单中心研究设计.
- 与MS和MDD共同诊断有关的人口统计数据的分析.
- 评估临床结果,包括疾病修饰疗法 (DMT) 的时间,MRI使用和死亡率.
主要成果:
- 黑人 pwMS 患MDD并发症的可能性更高;西班牙裔 pwMS 患MDD并发症的可能性更低.
- MDD并发症与开始DMT的显著延迟有关,特别是当MS后被诊断时.
- 患有MDD的住院pwMS患者减少了MRI使用,早期的MDD诊断前的MS与进一步的MRI减少和死亡率增加有关.
结论:
- 人口因素显著影响pwMS中MDD诊断.
- 多发性硬化症并发症是影响医疗保健资源利用率和MS患者健康结果的关键因素.
- 与MS诊断相比,MDD诊断的时间影响临床轨迹和死亡率.
相关概念视频
Depressive Disorders: MDD and Dysthymia
664
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
664
Depressive Disorders: Etiology
444
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
444
Depression: Overview
794
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
794
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Bipolar Disorder
625
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
625
Diagnostic and Statistical Manual of Mental Disorders (DSM)
1.1K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.1K


